Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theo Rispens

Showing results (231-240 of 276) with videos related to

Pageof 28
Sort By:
Annals of the Rheumatic Diseases|January 15, 2015
Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritisYoann Rombouts, Annemiek Willemze, Joyce J B C van Beers, et al.
JAMA Dermatology|September 19, 2019
Association of Serum Ustekinumab Levels With Clinical Response in PsoriasisTeresa Tsakok, Nina Wilson, Nick Dand, et al.
British Journal of Clinical Pharmacology|January 6, 2021
Comprehensive evaluation of microneedle-based intradermal adalimumab delivery vs. subcutaneous administration: results of a randomized controlled clinical trialJustin Jacobse, Wouter Ten Voorde, Anushka Tandon, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 17, 2026
Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose AdalimumabAnika M Valk, Jolinde van Strien, Ninotska Derksen, et al.
Plos One|June 5, 2025
Remote early detection of SARS-CoV-2 infections using a wearable-based algorithm: Results from the COVID-RED study, a prospective randomised single-blinded crossover trialLaura C Zwiers, Timo B Brakenhoff, Brianna M Goodale, et al.
Ebiomedicine|June 25, 2022
Immunoassay for quantification of antigen-specific IgG fucosylationTonći Šuštić, Julie Van Coillie, Mads Delbo Larsen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 1, 2024
Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: A nested case-control studyPim Bouwmans, S Reshwan K Malahe, A Lianne Messchendorp, et al.
European Journal of Immunology|March 12, 2025
Age and Latent Cytomegalovirus Infection Do Not Affect the Magnitude of De Novo SARS-CoV-2-Specific CD8<sup>+</sup> T Cell ResponsesJet van den Dijssel, Veronique A L Konijn, Mariël C Duurland, et al.
Microbiology Spectrum|September 15, 2021
Saliva SARS-CoV-2 Antibody Prevalence in ChildrenMaya W Keuning, Marloes Grobben, Anne-Elise C de Groen, et al.
Clinical and Translational Science|April 30, 2026
Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Ruoheng Wei, et al.
Pageof 28

Showing results (231-240 of 276) with videos related to

Sort By:
Pageof 28
Annals of the Rheumatic Diseases|January 15, 2015
Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritisYoann Rombouts, Annemiek Willemze, Joyce J B C van Beers, et al.
JAMA Dermatology|September 19, 2019
Association of Serum Ustekinumab Levels With Clinical Response in PsoriasisTeresa Tsakok, Nina Wilson, Nick Dand, et al.
British Journal of Clinical Pharmacology|January 6, 2021
Comprehensive evaluation of microneedle-based intradermal adalimumab delivery vs. subcutaneous administration: results of a randomized controlled clinical trialJustin Jacobse, Wouter Ten Voorde, Anushka Tandon, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 17, 2026
Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose AdalimumabAnika M Valk, Jolinde van Strien, Ninotska Derksen, et al.
Plos One|June 5, 2025
Remote early detection of SARS-CoV-2 infections using a wearable-based algorithm: Results from the COVID-RED study, a prospective randomised single-blinded crossover trialLaura C Zwiers, Timo B Brakenhoff, Brianna M Goodale, et al.
Ebiomedicine|June 25, 2022
Immunoassay for quantification of antigen-specific IgG fucosylationTonći Šuštić, Julie Van Coillie, Mads Delbo Larsen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 1, 2024
Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: A nested case-control studyPim Bouwmans, S Reshwan K Malahe, A Lianne Messchendorp, et al.
European Journal of Immunology|March 12, 2025
Age and Latent Cytomegalovirus Infection Do Not Affect the Magnitude of De Novo SARS-CoV-2-Specific CD8<sup>+</sup> T Cell ResponsesJet van den Dijssel, Veronique A L Konijn, Mariël C Duurland, et al.
Microbiology Spectrum|September 15, 2021
Saliva SARS-CoV-2 Antibody Prevalence in ChildrenMaya W Keuning, Marloes Grobben, Anne-Elise C de Groen, et al.
Clinical and Translational Science|April 30, 2026
Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Ruoheng Wei, et al.
Pageof 28